dual p53-mdm2/mdmx inhibitors (Adamed)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual p53-mdm2/mdmx inhibitors (Adamed)
Drug Alias Namep53-mdm2 and mdm4 interactions inhibitors (Adamed)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein Mdm4 inhibitorsp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2Protein Mdm4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamed
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A